4.5 Article

Mechanism of IRSp53 inhibition and combinatorial activation by Cdc42 and downstream effectors

期刊

NATURE STRUCTURAL & MOLECULAR BIOLOGY
卷 21, 期 4, 页码 413-U163

出版社

NATURE PUBLISHING GROUP
DOI: 10.1038/nsmb.2781

关键词

-

资金

  1. US National Institutes of Health (NIH) [R01 MH087950]
  2. NIH [T32 AR053461, GM095977]
  3. American Cancer Society [PF-13-033-01-DMC]
  4. Associazione Italiana per la Ricerca sul Cancro grant [IG-2013-14104]
  5. Industrial Macromolecular Crystallography Association through the Hauptman-Woodward Medical Research Institute
  6. US Department of Energy [DE-AC02-06CH11357]

向作者/读者索取更多资源

The Rho family GTPase effector IRSp53 has essential roles in filopodia formation and neuronal development, but its regulatory mechanism is poorly understood. IRSp53 contains a membrane-binding BAR domain followed by an unconventional CRIB motif that overlaps with a proline-rich region (CRIB-PR) and an SH3 domain that recruits actin cytoskeleton effectors. Using a fluorescence reporter assay, we show that human IRSp53 adopts a closed inactive conformation that opens synergistically with the binding of human Cdc42 to the CRIB-PR and effector proteins, such as the tumor-promoting factor Eps8, to the SH3 domain. The crystal structure of Cdc42 bound to the CRIB-PR reveals a new mode of effector binding to Rho family GTPases. Structure-inspired mutations disrupt autoinhibition and Cdc42 binding in vitro and decouple Cdc42-and IRSp53-dependent filopodia formation in cells. The data support a combinatorial mechanism of IRSp53 activation.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据